Exhibit 99.1

 

 

 

Akerna Announces Financial Results for the First Quarter 2021

 

Software revenue up 62%, total revenue up 31% year-over-year

 

DENVER, May 10, 2021 -- Akerna (Nasdaq: KERN), an enterprise software, leading compliance technology provider and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), today reported its unaudited financial results for the quarter ended March 31, 2021.

 

“Our first quarter was a strong start to 2021, with increasing demand for our platform driving 62% year over year software growth,” said Jessica Billingsley, CEO of Akerna. “With the leadership position we have in our core business and capabilities we have integrated to take advantage of new opportunities such as payments with the passage of the Safe Banking Act, new state initiatives, and ultimately U.S. federal legalization, we believe we are well positioned to capitalize on the approaching inflection point in industry growth.”

 

Akerna is the technology ecosystem for cannabis. Through its family of software, which includes MJ Platform, Viridian Sciences, Ample Organics, Trellis, Leaf Data Systems, Last Call Analytics, and solo sciences, Akerna provides the only scalable cannabis ERP solution offering compliance, data, taxation, payments, seed-to-sale, track-and-trace, and consulting to operators, governments, and brands. In doing so, Akerna creates one of the world’s most transparent and accountable consumer packaged goods supply chains on a global scale.

 

Cannabis companies looking to scale alongside the rapidly expanding industry must leverage the right tools, and enterprise class software is essential to do so.

 

First Quarter 2021 Financial Highlights

 

Software revenue was $3.8 million, up 62% year over year
  
Total revenue was $4.0 million, up 31% year over year
  
Gross profit was $2.6 million, up 53% year over year
  
Net loss was $6.3 million compared to a net loss of $4.8 million in the same period last year
  
Adjusted EBITDA was negative $1.8 million compared to negative Adjusted EBITDA of $3.2 million for the same quarter
  
Cash was $15.4 million as of March 31, 2021, compared to $17.8 million as of December 31, 2020

 

See “Explanation of Non-GAAP Financial Measures” below

 

First Quarter 2021 Key Metrics

 

Total SaaS ARR of $15.7 million, up 73% year over year
  
Average new MJ Platform order up 29% year over year
  
MJ Platform transaction volume up 51% year over year
  
Retail order volume up 51% year over year
  
Retail order value up 29% year over year
  
New Bookings ARR of approximately $1M

 

 

 

First Quarter 2021 Operational Highlights

 

Akerna’s MJ Platform achieves SAP certified integration with SAP NetWeaver
  
Announced acquisition of Viridian Sciences, SAP Business One software for cannabis, with positive cash flow contribution
  
Nominated new board member, Barry Fishman

 

The foregoing financial results are preliminary in nature. Final financial results and other disclosures will be reported in Akerna’s quarterly report on Form 10-Q and may differ materially from the results and disclosures today due to, among other things, the completion of final review procedures, the occurrence of subsequent events or the discovery of additional information. You are encouraged to review the Form 10-Q in detail.

 

Conference Call Details

 

Akerna will host a conference call tomorrow, Tuesday, May 11, 2021, at 8:30 a.m. Eastern Time to discuss its financial results and business highlights. A question-and-answer session will follow prepared remarks.

 

Interested parties may listen to the call by dialing:

 

Toll-Free: 1-877-407-3982

Toll / International: +1-201-493-6780

Conference ID: 13719091

 

The conference call will also be available via a live, listen-only webcast and can be accessed through the Investor Relations section of Akerna’s website, https://ir.akerna.com/

 

To be included on the Company’s email distribution list, please sign up at https://ir.akerna.com/news-events/email-alerts

 

About Akerna

 

Akerna (Nasdaq: KERN) is an enterprise software company focused on compliantly serving the cannabis, hemp, and CBD industry. First launched in 2010, Akerna has tracked more than $20 billion in cannabis sales to date and is the first cannabis software company listed on Nasdaq. The company’s cornerstone technology, MJ Platform, the world’s leading infrastructure as a service platform, powers retailers, manufacturers, brands, distributors, and cultivators.

 

For more information, visit https://www.akerna.com/.

 

Investor Contacts

Sapphire Investor Relations, LLC

Erica Mannion or Michael Funari

(617) 542-6180

IR@akerna.com

 

2

 

 

Forward Looking Statements

 

Certain statements made in this release are “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. Such forward-looking statements include but are not limited to statements regarding our preliminary financial results which may differ from our final financial results, our preparation for a potential post-legalization landscape, our believe enterprise capabilities, including comprehensive compliance solutions and financial reporting integrations, will become increasingly important to the future leaders of the cannabis industry and the timing for management’s conference call in relation to our quarterly results. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of significant known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside Akerna’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others that may affect actual results or outcomes, include (i) Akerna’s ability to maintain relationships with customers and suppliers and retain its management and key employees, (ii) changes in applicable laws or regulations, (iii) changes in the market place due to the coronavirus pandemic or other market factors, (iv) and other risks and uncertainties disclosed from time to time in Akerna’s filings with the U.S. Securities and Exchange Commission, including those under “Risk Factors” therein. You are cautioned not to place undue reliance on forward-looking statements. All information herein speaks only as of the date hereof, in the case of information about Akerna, or the date of such information, in the case of information from persons other than Akerna. Akerna undertakes no duty to update or revise the information contained herein. Forecasts and estimates regarding Akerna’s industry and end markets are based on sources believed to be reliable; however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part.

 

Explanation of Non-GAAP Financial Measures:

 

In addition to our results determined in accordance with U.S. generally accepted accounting principles (“GAAP”), we believe the following non-GAAP measures are useful in evaluating our operating performance. We use the following non-GAAP financial information to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that non-GAAP financial information, when taken collectively, may be helpful to investors because it provides consistency and comparability with past financial performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool, and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP.

 

Investors are cautioned that there are material limitations associated with the use of non-GAAP financial measures as an analytical tool. Other companies, including companies in our industry, may calculate similarly titled non-GAAP measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures as tools for comparison. We attempt compensate for these limitations by providing specific information regarding the GAAP items excluded from these non-GAAP financial measures.

 

Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures and not rely on any single financial measure to evaluate our business.

 

Adjusted EBITDA

 

We believe that Adjusted EBITDA, when considered with the financial statements determined in accordance with GAAP, is helpful to investors in understanding our performance and allows for comparison of our performance and credit strength to our peers. Adjusted EBITDA should not be considered alternatives to net loss as determined in accordance with GAAP as indicators of our performance or liquidity.

 

3

 

 

We define EBITDA as net loss before interest expense, provision for income taxes, depreciation and amortization. We calculate Adjusted EBITDA as EBITDA further adjusted to exclude the effects of the following items for the reasons set forth below:

 

Impairment of long-lived assets, because it’s a non-cash, non-recurring item, which effects the comparability of results of operations and liquidity;
  
Stock-based compensation expense, because this represents a non-cash charge and our mix of cash and share-based compensation may differ from other companies, which effects the comparability of results of operations and liquidity;
  
Cost incurred in connection with business combinations that are required to be expensed as incurred in accordance with GAAP, because business combination related costs are specific to the complexity and size of the underlying transactions as well as the frequency of our acquisition activity these costs are not reflective of our ongoing operations
  
Costs incurred in connection with debt issuance when we elect the fair value option to account for the debt instrument because if we had not elected the fair value option such costs would be recognized as an adjustment to the effective interest and excluded from EBITDA
  
Restructuring costs because we believe these costs are not representative of operating performance;
  
Equity in earnings (losses) of investees because our share of the operations of investees is not representative of our own operating performance and may not be monetized for a number of years; and
  
Other non-operating expenses which includes a one-time gain on asset sale, which effects the comparability of results of operations and liquidity;

 

Related Non-GAAP Expense Measure

 

We reference in our earnings call non-GAAP Operating Expenses. We believe that this non-GAAP financial measure, when considered with the financial statements determined in accordance with GAAP, is helpful to management and investors in understanding our performance quarter over quarter and to the comparable quarter in our prior fiscal year by excluding the same items we exclude from EBITDA to derive Adjusted EBITDA that are included in GAAP operating expenses, as set forth above (impairment of long-lived assets, stock-based compensation expense, costs incurred with business combinations, costs incurred in connection with debt issuance, restructuring costs and certain other non-operating expenses, as described above) for the same reasons stated above-- principally, that these expenses are not, in management’s opinion, easily comparable across reporting periods, are not reflective of ongoing operations and/or are not representative of our operating performance.

 

We define non-GAAP Operating Expenses, as GAAP Operating Expenses, excluding impairment of long-lived assets, stock-based compensation expense, costs incurred with business combinations, costs incurred in connection with debt issuance and restructuring costs.

 

This non-GAAP expense measure should not be considered an alternative to the corresponding GAAP financial measure as determined in accordance with GAAP as an indicator of our performance or liquidity. Please review the tables provided below, for a reconciliation of this non-GAAP expense measure to the corresponding GAAP financial measure.

 

The reconciliation of the above non-GAAP financial measures for the quarter ended March 31, 2021 are presented in the tables below. For comparative purposes, the reconciliation of these non-GAAP financial measures in the prior quarter ended December 31, 2020 are contained in our press release for that quarter dated March 22, 2021 and available on our website at www.akerna.com or in our current report on Form 8-K filed with the Securities and Exchange Commission on March 22, 2021 and available here: https://www.sec.gov/Archives/edgar/data/1755953/000121390021016988/ea138212ex99-1_akerna.htm

 

4

 

 

Akerna Corp.

 Condensed Consolidated Balance Sheets

 

   March 31,   December 31, 
   2021   2020 
Assets   (unaudited)     
Current assets:        
Cash  $15,426,759   $17,840,640 
Restricted cash   500,000    500,000 
Accounts receivable, net   1,887,093    1,753,547 
Prepaid expenses and other current assets   2,095,614    2,458,727 
Total current assets   19,909,466    22,552,914 
           
Fixed assets, net   1,139,689    1,193,433 
Investment, net   229,883    233,664 
Capitalized software, net   4,201,065    3,925,739 
Intangible assets, net   6,974,546    7,388,795 
Goodwill   41,874,527    41,874,527 
Total Assets  $74,329,176   $77,169,072 
           
Liabilities and Equity          
Current liabilities          
Accounts payable, accrued expenses and other accrued liabilities  $3,060,746   $3,188,576 
Deferred revenue   1,105,869    843,900 
Current portion of long-term debt   8,781,302    11,707,363 
Total current liabilities   12,947,917    15,739,839 
           
Long-term debt, less current portion   1,127,843    3,895,237 
Total liabilities   14,075,760    19,635,076 
           
Commitments and contingencies          
Equity:          
Preferred stock, par value $0.0001; 5,000,000 shares authorized, none are issued and outstanding at March 31, 2021 and December 31, 2020        
Special voting preferred stock, par value $0.0001; 1 share authorized, issued and outstanding as of March 31, 2021 and December 31, 2020, with $1.00 preference in liquidation; exchangeable shares, no par value, 1,647,287 and 2,667,349 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively (See Note 4)   12,601,744    20,405,219 
Common stock, par value $0.0001; 75,000,000 shares authorized, 23,067,517 and 19,901,248 issued and outstanding at March 31, 2021 and December 31, 2020, respectively   2,306    1,990 
Additional paid-in capital   111,908,399    95,090,883 
Accumulated other comprehensive loss   (104,727)   (91,497)
Accumulated deficit   (64,154,306)   (57,872,599)
Total equity  $60,253,416   $57,533,996 
Total liabilities and equity  $74,329,176   $77,169,072 

 

5

 

 

Akerna Corp.

 Condensed Consolidated Statements of Operations

(unaudited)

 

   For the Three Months Ended 
   March 31, 
   2021   2020 
Revenues        
Software  $3,795,153   $2,346,310 
Consulting   172,747    692,584 
Other   46,124    31,652 
Total revenues   4,014,024    3,070,546 
Cost of revenues   1,454,167    1,396,219 
           
Gross profit   2,559,857    1,674,327 
           
Operating expenses:          
Product development   1,424,100    874,787 
Sales and marketing   1,735,915    2,040,751 
General and administrative   1,852,962    3,457,262 
Depreciation and amortization   1,052,883    180,229 
Total operating expenses   6,065,860    6,553,029 
           
Loss from operations   (3,506,003)   (4,878,702)
           
Other (expense) income:          
Interest expense   (776,181)    
Interest income   1,801    33,522 
Change in fair value of convertible notes   (1,991,272)    
Other expense, net       (124)
Total other (expense) income   (2,765,652)   33,398 
           
Net loss before income taxes and equity in losses of investee   (6,271,655)   (4,845,304)
Income tax expense   (6,270)    
Equity in losses of investee   (3,782)    
Net loss   (6,281,707)   (4,845,304)
Net loss attributable to noncontrolling interest in consolidated subsidiary       101,175 
Net loss attributable to Akerna shareholders  $(6,281,707)  $(4,744,129)
           
Basic and diluted weighted average common stock outstanding   22,209,072    12,469,737 
Basic and diluted net loss per common share  $(0.28)  $(0.38)

 

6

 

 

Akerna Corp.

 Condensed Consolidated Statements of Cash Flows

(unaudited)

 

   For the Three Months Ended 
   March 31, 
   2021   2020 
Cash flows from operating activities        
Net loss  $(6,281,707)  $(4,845,304)
Adjustment to reconcile net loss to net cash used in operating activities:          
Equity in losses of investment   3,782     
Bad debt   (10,516)   208,729 
Stock-based compensation expense   503,379    301,948 
Amortization of deferred contract cost   118,519     
Non-cash interest expense   769,773     
Depreciation and amortization   1,052,882    2,824 
Foreign currency loss   (18,801)    
Change in fair value of convertible notes   1,991,272     
Change in fair value of contingent consideration        
Changes in operating assets and liabilities:          
Accounts receivable   (177,832)   234,203 
Prepaid expenses and other current assets   236,339    (631,319)
Other assets       (58,925)
Accounts payable and accrued liabilities   152,455    975,312 
Deferred revenue   286,637    (101,237)
Net cash used in operating activities   (1,373,818)   (3,913,769)
           
Cash flows from investing activities          
Developed software additions   (704,637)    
Furniture, fixtures, and equipment additions       (53,621)
Cash paid for business combination, net of cash acquired       101,340 
Net cash used in investing activities   (704,637)   47,719 
           
Cash flows from financing activities          
Value of shares withheld for related to tax withholdings   (333,847)    
Net cash (used in) provided by financing activities   (333,847)    
Effect of exchange rate changes on cash and restricted cash   (1,579)    
Net change in cash and restricted cash   (2,413,881)   (3,866,050)
Cash and restricted cash - beginning of period   18,340,640    19,280,897 
Cash and restricted cash - end of period  $15,926,759   $15,414,847 
Cash paid for interest        
Cash paid for taxes        
Supplemental Disclosure of non-cash investing and financing activity:          
Settlement of convertible notes in common stock   8,467,292     
Conversion of exchangeable shares to common stock   7,803,475     
Settlement of other liabilities in common stock   377,325     

 

7

 

 

Akerna Corp.

Earnings Before Interest, Taxes, Depreciation and Amortization, and Adjusted EBITDA

The reconciliation of net loss to EBITDA and Adjusted EBITDA is as follows:

(unaudited)

 

   Three Months Ended
March 31,
 
   2021   2020 
         
Net loss  $(6,281,707)  $(4,845,305)
Interest income   (1,801)   (33,522)
Interest expense   776,181    - 
Change in fair value of convertible notes   1,991,272    - 
Depreciation and amortization   1,052,883    180,229 
Income tax expense   6,270    - 
EBITDA  $(2,456,902)  $(4,698,598)
           
Stock compensation   503,379    301,949 
Acquisition related expense   43,991    1,218,432 
Financing related expense   17,834    - 
Restructuring   47,187    - 
Equity in losses of investee   3,782    - 
Other expense (income)   -    124 
Adjusted EBITDA  $(1,840,729)  $(3,178,093)

 

8

 

 

Akerna Corp.

The reconciliation of operating expenses to non-GAAP operating expenses is as follows:

(unaudited)

 

   Three Months Ended
March 31,
 
   2021   2020 
         
Operating expenses  $6,065,860   $6,553,029 
           
Adjustments:          
Depreciation and amortization   1,052,883    180,229 
Stock-based compensation expense   503,379    301,949 
Business combination and merger related costs   43,991    1,218,432 
Financing related expense   17,834    - 
Restructuring charges   47,187    - 
Non-GAAP operating expenses  $4,400,586   $4,852,420 

 

 

9

 

 

 


The following information was filed by Akerna Corp. (KERN) on Tuesday, May 11, 2021 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Akerna Corp.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Akerna Corp..

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account